Brief: Foghorn Therapeutics Provides 2023 Outlook And Full Year 2022 Corporate Update
09/03/2023 12:38
March 9 (Reuters) - Foghorn Therapeutics Inc. FHTX.O :
* FOGHORN THERAPEUTICS PROVIDES 2023 OUTLOOK AND FULL YEAR
2022
CORPORATE UPDATE
* FOGHORN THERAPEUTICS INC.- CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES OF $345.8 MILLION, AS OF DECEMBER 31, 2022
* FOGHORN THERAPEUTICS INC.- CASH RUNWAY INTO SECOND HALF OF
2025
Source text for Eikon: ID:nGNX9WLCqB
Further company coverage: FHTX.O
((Reuters.Briefs@thomsonreuters.com;;))